Quarterly Statement Of Cash Flows

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7328181

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,086,000,000 JPY
-2,262,000,000 JPY
Interest and dividends received
1,261,000,000 JPY
1,302,000,000 JPY
Interest paid
-18,000,000 JPY
-20,000,000 JPY
Income taxes paid
-1,834,000,000 JPY
-5,699,000,000 JPY
Net cash provided by (used in) operating activities
-1,677,000,000 JPY
-6,679,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,201,000,000 JPY
-2,103,000,000 JPY
Proceeds from sale of property, plant and equipment
175,000,000 JPY
78,000,000 JPY
Purchase of investment securities
-2,349,000,000 JPY
-991,000,000 JPY
Loan advances
-3,000,000 JPY
-8,000,000 JPY
Proceeds from collection of loans receivable
5,000,000 JPY
11,000,000 JPY
Other, net
-59,000,000 JPY
35,000,000 JPY
Net cash provided by (used in) investing activities
8,690,000,000 JPY
6,001,000,000 JPY
Cash flows from financing activities
Repayments of short-term borrowings
-150,000,000 JPY
-150,000,000 JPY
Purchase of treasury shares
-6,000,000,000 JPY
0 JPY
Dividends paid
-3,722,000,000 JPY
-3,135,000,000 JPY
Net cash provided by (used in) financing activities
-10,006,000,000 JPY
-3,420,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-3,000,000 JPY
-21,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-2,997,000,000 JPY
-4,120,000,000 JPY
Cash and cash equivalents
45,887,000,000 JPY
48,884,000,000 JPY
53,004,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.